4.7 Review

Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018

期刊

CELL DEATH AND DIFFERENTIATION
卷 25, 期 3, 页码 486-541

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/s41418-017-0012-4

关键词

-

资金

  1. Department of Radiation Oncology of Weill Cornell Medical College (New York, US)
  2. Sotio a.c. (Prague, Czech Republic)
  3. Associazione Italiana per la Ricerca sul Cancro (AIRC) [20417]
  4. Ministero Italiano della Salute [RF_GR-2011-02351355]
  5. Ministero Italiano dell'Istruzione, dell'Universita e della Ricerca (MIUR)
  6. French Ligue contre le Cancer (equipe labellisee)
  7. Agence National de la Recherche (ANR)-Projets blancs
  8. ANR
  9. ERA-Net for Research on Rare Diseases
  10. Association pour la recherche sur le cancer (ARC)
  11. Canceropole Ile-de-France
  12. Institut National du Cancer (INCa)
  13. Institut Universitaire de France
  14. Fondation pour la Recherche Medicale (FRM)
  15. European Commission (ArtForce)
  16. European Research Council (ERC)
  17. LeDucq Foundation
  18. LabEx Immuno-Oncology
  19. SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE)
  20. SIRIC Cancer Research and Personalized Medicine (CARPEM)
  21. Paris Alliance of Cancer Research Institutes (PACRI)
  22. Department of Radiation Oncology of Weill Cornell Medical College (New York, US)
  23. Sotio a.c. (Prague, Czech Republic)
  24. Associazione Italiana per la Ricerca sul Cancro (AIRC) [20417]
  25. Ministero Italiano della Salute [RF_GR-2011-02351355]
  26. Ministero Italiano dell'Istruzione, dell'Universita e della Ricerca (MIUR)
  27. French Ligue contre le Cancer (equipe labellisee)
  28. Agence National de la Recherche (ANR)-Projets blancs
  29. ANR
  30. ERA-Net for Research on Rare Diseases
  31. Association pour la recherche sur le cancer (ARC)
  32. Canceropole Ile-de-France
  33. Institut National du Cancer (INCa)
  34. Institut Universitaire de France
  35. Fondation pour la Recherche Medicale (FRM)
  36. European Commission (ArtForce)
  37. European Research Council (ERC)
  38. LeDucq Foundation
  39. LabEx Immuno-Oncology
  40. SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE)
  41. SIRIC Cancer Research and Personalized Medicine (CARPEM)
  42. Paris Alliance of Cancer Research Institutes (PACRI)
  43. Grants-in-Aid for Scientific Research [16K15115, 15H05785] Funding Source: KAKEN
  44. MRC [MC_UU_00001/7, MC_UP_A600_1109, MC_PC_12007, MC_UU_00025/4, MR/M019217/1, MC_U132685863, MC_U132670600] Funding Source: UKRI
  45. Cancer Research UK [18274, 18278, 26855, 15816, 22903, 20145] Funding Source: researchfish
  46. Medical Research Council [MC_U132670600, MC_UU_00025/4, MC_UU_00001/7, MC_UP_A600_1109, MC_U132685863, MC_PC_12007] Funding Source: researchfish
  47. The Francis Crick Institute [10557, 10682] Funding Source: researchfish

向作者/读者索取更多资源

Over the past decade, the Nomenclature Committee on Cell Death (NCCD) has formulated guidelines for the definition and interpretation of cell death from morphological, biochemical, and functional perspectives. Since the field continues to expand and novel mechanisms that orchestrate multiple cell death pathways are unveiled, we propose an updated classification of cell death subroutines focusing on mechanistic and essential (as opposed to correlative and dispensable) aspects of the process. As we provide molecularly oriented definitions of terms including intrinsic apoptosis, extrinsic apoptosis, mitochondrial permeability transition (MPT)-driven necrosis, necroptosis, ferroptosis, pyroptosis, parthanatos, entotic cell death, NETotic cell death, lysosome-dependent cell death, autophagy-dependent cell death, immunogenic cell death, cellular senescence, and mitotic catastrophe, we discuss the utility of neologisms that refer to highly specialized instances of these processes. The mission of the NCCD is to provide a widely accepted nomenclature on cell death in support of the continued development of the field.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据